Sarda Proteins Announces 35th AGM Details

Sarda Proteins Ltd scheduled its 35th AGM for September 30, 2026, seeking approval for a Rs 1,000 crore borrowing limit.

Reader Takeaway: Shareholders will vote on enabling resolutions for future capital expansion and the appointment of new statutory auditors.

What just happened

Sarda Proteins Ltd issued the notice for its 35th Annual General Meeting (AGM) to be held on Wednesday, September 30, 2026, at 11:00 A.M. via Video Conferencing or Other Audio Visual Means. The company has fixed September 23, 2026, as the cut-off date for e-voting eligibility. Additionally, the share transfer books will remain closed from September 24 to September 30, 2026.

Why this matters

The meeting includes critical ordinary business such as the adoption of financial statements for the fiscal year ended March 31, 2026, and the formal appointment of M/s. A H Mandaliya & Associates as statutory auditors for a five-year term. Notably, the board is seeking special resolutions to authorize borrowing powers and loan/investment limits of up to Rs 1,000 crore each under Section 186 of the Companies Act.

Management Rationale

The company states that these authorizations are intended to provide the necessary financial flexibility to support business growth, working capital requirements, and potential capital expenditure or project development. These resolutions serve as an enabling framework to expedite future operational needs without needing repeated shareholder approvals for individual transactions within the specified limits.

What to track next

Shareholders should monitor the company’s post-AGM disclosures to verify the passage of these special resolutions. Investors should also review the annual report for further details on the planned utilization of the proposed borrowing limits.